Nature Reviews Gastroenterology & Hepatology
Scope & Guideline
Empowering Professionals with Essential Knowledge
Introduction
Aims and Scopes
- Microbiome and Gut Health:
The journal emphasizes the role of the gut microbiome in gastrointestinal health and disease, exploring its interactions with host physiology, immune responses, and its implications for conditions such as inflammatory bowel disease (IBD), liver diseases, and metabolic disorders. - Liver Diseases and Management:
A significant focus is placed on various liver diseases, including hepatitis, nonalcoholic fatty liver disease (NAFLD), and hepatocellular carcinoma (HCC). The journal discusses emerging therapies, clinical trial outcomes, and the pathophysiological mechanisms underlying these conditions. - Innovative Therapeutics and Clinical Trials:
Nature Reviews Gastroenterology & Hepatology highlights innovative therapeutic strategies, including the use of biologics, small molecules, and regenerative medicine approaches, along with detailed discussions on the design and outcomes of clinical trials. - Immunology and Inflammation:
The journal explores the immunological aspects of gastrointestinal and liver diseases, focusing on the roles of immune cells, inflammatory pathways, and the impact of immunotherapy on treatment outcomes. - Translational Research and Precision Medicine:
There is a strong emphasis on the translation of basic research findings into clinical practice, with a focus on precision medicine approaches that tailor treatments to individual patient characteristics and disease mechanisms. - Public Health and Epidemiology:
The journal also addresses the public health implications of gastrointestinal and liver diseases, including epidemiological trends, prevention strategies, and health disparities.
Trending and Emerging
- Artificial Intelligence and Machine Learning:
There is a notable increase in the exploration of artificial intelligence (AI) and machine learning applications in gastroenterology, particularly in diagnostic imaging, predictive analytics, and personalized treatment plans. - Microbiome Research and Therapeutics:
Research focusing on the gut microbiome as a therapeutic target is rapidly expanding, with increasing interest in microbiome modulation for managing gastrointestinal and liver diseases. - Patient-Centered Care and Health Equity:
Emerging themes around patient-centered care and health equity are gaining traction, emphasizing the importance of addressing social determinants of health and ensuring equitable access to care. - Immunotherapy and Novel Therapeutics:
The trend towards immunotherapy and other novel therapeutic approaches for treating liver cancer and IBD is growing, reflecting advancements in understanding disease mechanisms and treatment outcomes. - Environmental and Lifestyle Factors:
There is a rising focus on the impact of environmental and lifestyle factors on gastrointestinal health, including the effects of diet, pollution, and socio-economic status on disease risk and management. - Digital Health and Telemedicine:
The integration of digital health technologies, including telemedicine, into clinical practice is an emerging area of interest, particularly in the context of managing chronic gastrointestinal conditions.
Declining or Waning
- Traditional Dietary Approaches:
There appears to be a waning interest in traditional dietary management strategies for gastrointestinal diseases, as newer therapeutic interventions and precision medicine approaches gain prominence in research and clinical practice. - Conventional Imaging Techniques:
The emphasis on conventional imaging techniques for diagnosing gastrointestinal and liver diseases is decreasing, with a growing focus on advanced imaging modalities and biomarkers that offer more precise and detailed insights. - Generalized Liver Disease Management:
The discussion around generalized management strategies for liver diseases is declining, as more nuanced and specific treatment protocols tailored to individual patient needs and disease subtypes are being developed. - Basic Science without Clinical Relevance:
There is less emphasis on purely basic science studies that do not have immediate clinical relevance, as the journal increasingly prioritizes research that bridges the gap between basic science and clinical application.
Similar Journals
Clinical Gastroenterology and Hepatology
Connecting Researchers and Clinicians for Better Health OutcomesClinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.
Journal of Clinical and Experimental Hepatology
Advancing liver health through groundbreaking research.The Journal of Clinical and Experimental Hepatology, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a premier platform dedicated to advancing the field of hepatology. With an ISSN of 0973-6883 and an E-ISSN of 2213-3453, this journal has gained recognition for its impactful contributions to both clinical practice and scientific research in the domain of liver health. Ranking in the Q2 quartile for Hepatology in 2023 and positioned at 33rd out of 82 in Scopus’s Hepatology category, it reflects a robust impact factor and a commitment to publishing high-quality, peer-reviewed articles. Researchers, clinicians, and students can engage with a wealth of open-access content covering the latest advancements, challenges, and insights in hepatology, as the journal aims to disseminate knowledge from 2011 through 2025. Join the community of experts as we explore critical developments in the understanding and treatment of liver diseases.
JHEP Reports
Bridging research and application for a healthier tomorrow.JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.
Hepatology Forum
Advancing liver health through innovative research.Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.
JGH Open
Bridging Knowledge Gaps in Digestive HealthJGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Pioneering research for a healthier digestive future.Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.
Gastroenterologia y Hepatologia
Fostering innovation in the diagnosis and treatment of liver diseases.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.
HEPATOLOGY
Pioneering innovative solutions for liver health challenges.HEPATOLOGY is a premier scholarly journal dedicated to advancing the field of liver research and clinical practice. Published by Lippincott Williams & Wilkins, this journal boasts an impressive impact factor and holds a prestigious position as one of the top-ranked publications in both Hepatology (Q1) and Medicine (miscellaneous, Q1) categories as of 2023. HEPATOLOGY, with its commitment to disseminating high-quality research since its inception in 1981, serves as an essential platform for researchers, clinicians, and students focusing on liver diseases, including hepatitis, cirrhosis, and liver cancer. The journal's editorial board comprises leading experts who guide the publication towards its objective of fostering innovation and collaboration in this critical area of health. Although it does not offer an open access model, HEPATOLOGY ensures that its comprehensive analyses, reviews, and groundbreaking studies are accessible to the global medical community. Join the discourse in hepatology and be a part of a transformative journey through this indispensable resource.
World Journal of Hepatology
Elevating the discourse on liver health and disease management.World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Unveiling Breakthroughs in Gastrointestinal and Liver ScienceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society, stands as a leading journal in the domains of gastroenterology, hepatology, and overall physiology. With an impressive impact factor and consistent ranking in the Q1 quartile across multiple categories, this journal provides a vital platform for disseminating advanced research and innovative findings related to gastrointestinal and liver physiology. Since its inception in 1980, the journal has fostered a community of researchers and clinicians dedicated to understanding and improving digestive and liver health. While maintaining a traditional subscription model, it ensures high-quality peer-reviewed content that is crucial for informed professional practice and academic inquiry. The journal’s Scopus ranks highlight its significant impact in the fields of gastroenterology and hepatology, making it an indispensable resource for academics and practitioners alike, eagerly exploring both foundational and cutting-edge topics in physiology.